Details for Patent: 5,461,031
✉ Email this page to a colleague
Summary for Patent: 5,461,031
Title: | Monomeric insulin analog formulations |
Abstract: | The present invention discloses various parenteral pharmaceutical formulations, which comprise: a monomeric insulin analog, zinc, protamine, and phenolic derivative. The analog formulations provide a prolonged duration of action. A process for preparing insulin analog-protamine formulations is also described. |
Inventor(s): | De Felippis; Michael R. (Indianapolis, IN) |
Assignee: | Eli Lilly and Company (Indianapolis, IN) |
Application Number: | 08/260,633 |
Patent Claim Types: see list of patent claims | Formulation; Process; Use; |
Drugs Protected by US Patent 5,461,031
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,461,031
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 408611 | ⤷ Try a Trial | |||
Austria | A101795 | ⤷ Try a Trial | |||
Australia | 1008300 | ⤷ Try a Trial | |||
Australia | 2168295 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |